03

2022-06

Enterprise Headlines | Hengbao Protection Nominated for the 2022 Autonomous Region Key Pre-IPO Enterprise Roadshow Review Meeting

Hengbao Protection Participates in the 2022 Autonomous Region Key Pre-IPO Enterprise Roadshow Review Meeting

2022-06-03

29

2022-04

Enterprise Headlines | Hengbao Protection Invited to Attend the Malaysia-China (Guangxi) Investment Forum and the 10th Anniversary Celebration of the China-Malaysia “Two Countries, Two Parks” Initiative

Hengbao Protection was invited to attend the Malaysia-China (Guangxi) Investment Forum and the 10th-anniversary celebration of the China-Malaysia “Two Countries, Two Parks” initiative.

2022-04-29

01

2021-11

Medical Device Innovation, A Brilliant Future | Dingxiangyuan’s Exclusive Interview with Mr. Hu Zhiqiang, General Manager of Hengbao Protective

From October 13 to 16, 2021, the 85th China International Medical Equipment Autumn Fair (CMEF) concluded successfully at the Shenzhen International Expo Center (Bao'an District).

2021-11-01

30

2021-06

[Guilin TV Report] Guilin Economic Development Zone: Study Party History, Feel Gratitude for the Party, and Clarify Our Mission—High-Quality Services Drive High-Standard Development of Enterprises in the Zone.

Guilin Hengbao Protective Equipment, under the organization of the Economic Development Zone, held a patriotic education themed event titled “Study Party History, Feel Gratitude to the Party, and Clarify Our Mission.”

2021-06-30

26

2021-05

[Guilin TV Report] The Guilin Municipal Government and Shenzhen Innovation Investment Group Sign a Strategic Cooperation Agreement.

At the inaugural Guilin Li River Medical and Healthcare Investment Forum, the Guilin Municipal Government signed a strategic cooperation agreement with Shenzhen Innovation Investment Group, and Guilin Hengbao received 100 million yuan in investment from Shenzhen Venture Capital.

2021-05-26

28

2020-02

According to a report by China Daily, Hengbao Group announced the development of a highly effective coronavirus inactivator.

On February 20, an inactivated coronavirus vaccine—invested in by Chinese-American entrepreneurs from Hubei Province—passed the testing conducted by ALG (ANALYTICAL LAB GROUP), a U.S. Food and Drug Administration–certified testing organization, and will soon begin production in Ohio, USA. Once this product, which has already been submitted for virus testing in China, is proven effective, it will promptly be deployed to assist China in its fight against the epidemic.

2020-02-28

< 123 >
Guilin Hengbao Health Protection Co., Ltd.
%{tishi_zhanwei}%